Automated description from the Alliance of Genome Resources (Release 3.1.1)
Predicted to have RNA helicase activity; chromatin binding activity; and nucleic acid binding activity. Involved in dosage compensation by inactivation of X chromosome. Predicted to localize to chromatin; cytoplasm; and nucleus. Is expressed in cerebral cortex ventricular layer; embryo; and oocyte. Orthologous to human UPF1 (UPF1 RNA helicase and ATPase).